By Thomas Smith, Julia Gamburg and Nick Marsillo
To say the past ten years have been uniquely challenging for insurance investors would be an understatement. As developed market interest rates fell and regulatory scrutiny increased, many investors turned to emerging market debt (EMD) to reach for the yield their portfolios required. Despite this increased willingness to invest in the asset class, we frequently field questions from clients and prospects in the insurance space about the inherent risks of EMD, especially when compared to developed markets. In this paper we address many of these commonly asked questions, including:
• How would you address concerns about the contagion effects of EM?
• How have EM credit fundamentals performed relative to developed markets over the years?
• Given the challenging market backdrop today, how would we position the EMD portfolio?
For the full report, please download the file:
Download (PDF | 3.54 MB)
You are navigating to web pages dedicated to MetLife Investment Management investment funds, which contain information regarding MetLife Investment Management Funds and other commingled investment vehicles managed by MetLife Investment Management. These pages are specific to Funds only, and will not contain information on MetLife Investment Management Advisory services. Please click the button below to acknowledge that you understand that the following pages are specific to MetLife Investment Management Funds and other commingled investment vehicles only. Click “Return to Page” to close this window.